'Benefits of AstraZeneca vaccine outweigh risks' - Sir Kent Woods

Sir Kent Woods, former CEO of the UK's medicines regulator, says that any risks associated with the AstraZeneca vaccine are outweighed by the benefits. This comes after a trial on children was halted to further investigate rare blood clotting issues.